$0.00

Chemotherapy Drugas Market

Name: Chemotherapy Drugs Market
SKU: 1472
Availability: InStock

Category: Healthcare

Report Preview

The global chemotherapy drugs market size was valued at USD 155.0 billion in 2021 and is projected to reach around USD 330.0 billion in 2030 exhibiting a CAGR of 7.5% in the forecasted period. The rising prevalence of cancer, increasing healthcare expenditure are driving the chemotherapy drugs are expected to increase the market growth. On the other hand, high cost associated with the chemotherapy drugs, side effects of chemotherapy drugs are some restraining factors limiting the growth.

Attribute	Key Insights
Estimated Market Value (2021)	155 USD Billion
Forecasted Market Value (2028)	330 Billion
CAGR % 2023-2028	7.5%
Leading Region	North America

The increasing prevalence of cancer is anticipated to improve the chemotherapy drug market’s growth rate. Cancer is the maximum cause of mortality globally, as per the World Health Organization (WHO), accounting for nearly 10 million deaths in 2020, or about one in every six deaths. About 400 000 children are diagnosed with cancer each year. Cervical cancer is the most common cancer in 23 of the world’s nations. Chemotherapy utilizes either site-specific or intravenous drug delivery. In spite of advances in cancer treatment technology, the disease still dues the lives of up to 8 million people per year. Chemotherapy or anti-cancer drugs are elements that can denature cancer cells by faltering their proliferation. Recently, in May 2022, Gland Pharma launched the Bortezomib for Injection in US. Bortezomib for injection is engaged for treating certain types of cancer containing multiple myeloma and mantle cell lymphoma. The chemotherapy drugs market is anticipated to boost during the forecasted period.

Since the emergence in December 2019, the COVID-19 virus has spread to each country on the planet, stimulating the World Health Organization (WHO) to state it a public health emergency. In November of 2019, the globe was traumatized to know the COVID-19 virus. In earlier years, there was no medical considerate or hint of such a virus that may have arranged the world to deal with the infection’s criticality. Lockdowns were ordered by governments all about the world to stop the virus from increasing. When tested against SARS-CoV-2, chemotherapy medicines such omycin, azithromycin, and pralatrexate that are used to treat lymphoma, showed progressive results in reducing COVID-19 virus. Companies of chemotherapy drugs have aided in COVID-19 times by spending in corona research initiatives, and they are expected to gain popularity and success in effective corona treatment.

Type Insights

By type, the chemotherapy drugs market is bifurcated into alkylating agents, anti-metabolites, plant alkaloids and terpenoids, podophyllotoxin, taxanes, topoisomerase inhibitor, anti-tumour antibiotics, hormones, monoclonal antibodies, and others. The alkylating agents segment is predicted to provide maximum share by 2021. Alkylating drugs were generally used from the start and are thus the best-studied chemotherapeutic drug. Though they can be used to treat a variety of cancers, they are most active against slow-growing malignancies. The effective mechanism of the drug and operative results have made it the most widely used and in-demand drug class in the chemotherapy drugs market, thus boosting market growth.

Indication Insights

In terms of indication, the chemotherapy drugs market is segmented into oncology/cancer, bone marrow diseases, immune system disorders, and others. The oncology/cancer segment is estimated to hold the maximum share in the evaluation timeframe, owing to the rising cases of cancer. The immune system disorders segment is anticipated to be the most profitable growing at a fastest CAGR. The incidence of cancer is rising globally, and there are several clear causes for this, including smoking, drinking, pollution, and others.

Region Insights

In 2021, North America dominates the chemotherapy drug market due to the presence of major manufacture of the product and growing geriatric population in this region. Moreover, high research and development expenditure and presence of skilled experts will further boost the market’s growth rate in this region.

Asia-Pacific is anticipated to propel during the forecast period owing to grown government awareness programs and increasing healthcare expenditure in this region. Also, rising number of generic drugs will further cushion the market’s growth rate in this region.

Key Companies Insights

To stay competitive in the global market, players are using new strategies such as new product development, mergers and acquisitions, joint ventures, and geographic expansions. Some of the key players operating in the global chemotherapy drugs market include:

Mylan N.V.
Merck & Co., Inc.
Allergan
AstraZeneca
AbbVie Inc.
Bayer AG
Teva Pharmaceutical Industries Ltd.
Bausch Health Companies Inc.
Fresenius Kabi AG
Amneal Pharmaceuticals LLC
LEO Pharma A/S
Johnson & Johnson Private Limited
Hoffmann-La Roche Ltd
Sanofi
Amgen Inc.
Eli Lilly & Company
Novartis AG
Other players

Some of the Recent Developments:

In April 2022, Sierra Oncology was acquired by GSK for $1.9 billion.
In September 2022, the US health regulator has accepted Lenalidomide capsule, a medication used to treat several types of cancer for Cipla.
In August 2022, the Indian Drugs Controller General permitted AstraZeneca India authorization to market Lynparza, a medication used to treat breast cancer.

Segments

By Indication

Oncology/Cancer
Bone Marrow Diseases
Immune System Disorders
Others

By Type

Alkylating Agents
Anti-metabolites
Plant Alkaloids and Terpenoids
Podophyllotoxin
Taxanes
Topoisomerase Inhibitor
Anti-Tumour Antibiotics
Hormones
Monoclonal Antibodies
Others

By Dosage Forms

Capsule
Tablets
Injections
Others

By Route of Administration

Oral
Parenteral
Intravenous
Subcutaneous
Others

By End Users

Hospitals
Specialty Clinics
Homecare
Others

By Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others

By Geography

North America
- S.
- Canada
- Mexico
Europe
- K.
- Germany
- France
- Italy
- Spain
- Russia
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- ASEAN
Latin America
- Brazil
- Argentina
- Colombia
MEA
- South Africa
- Saudi Arabia
- UAE
- Egypt

Global Chemotherapy Drugs Introduction and Market Overview
- Objectives of the Study
- Global Chemotherapy Drugs Scope and Market Estimation
  - Global Chemotherapy Drugs Overall Market Size, Revenue (US$ Mn), Market CAGR (%), Market forecast (2023 – 2032)
  - Global Chemotherapy Drugs Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 – 2032
- Market Segmentation
  - Indication of Global Chemotherapy Drugs
  - Type of Global Chemotherapy Drugs
  - Dosage Forms of Global Chemotherapy Drugs
  - Route of Administration of Global Chemotherapy Drugs
  - End User of Global Chemotherapy Drugs
  - Distribution Channel of Global Chemotherapy Drugs
  - Region of Global Chemotherapy Drugs

Executive Summary
Market Factor Analysis
- Global Chemotherapy Drugs Industry Trends under COVID-19 Outbreak
  - Global COVID-19 Status Overview
  - Influence of COVID-19 Outbreak on Global Chemotherapy Drugs Industry Development
- Market Dynamics, By Region
  - Drivers
  - Limitations
  - Opportunities
  - Impact Analysis of Drivers and Restraints
- Ecosystem / Value Chain Analysis
  - Raw Materials / Components Suppliers
  - Manufacturers / Vendors
  - Distributors
  - Buyers / End-users
  - Forward Integration & Backward Integration of Key Stakeholders
- Global Chemotherapy Drugs – Pricing Trends Analysis & Average Selling Prices (ASPs)
- End-User / Customer Preferences & Consumer Surveys
- Technology Roadmap & Key Innovations /Developments
- Key Mandates & Regulatory Scenario Analysis
- Patents Landscape
- Manufacturing Cost Structure Share Analysis
- Key Mergers & Acquisitions, Expansions, JVs, Funding / VCs, etc.
- Porter’s Five Forces Analysis
  - Bargaining Power of Suppliers
  - Bargaining Power of Buyers
  - Threat of Substitutes
  - Threat of New Entrants
  - Competitive Rivalry
- PEST Analysis
  - Political Factors
  - Economic Factors
  - Social Factors
  - Technological Factors
- SWOT Analysis
- Russia-Ukraine War Impacts Analysis
- ANSOFF Matrix
  - Market Penetration Strategy
  - Product Development Strategy
  - Market Development Strategy
  - Diversification Strategy
- Inflation Impacts Analysis
  - Supply Side Impacts
  - Demand Side Impacts
  - Outlook in 2023 & Beyond
- Market Investment Feasibility Analysis
- Opportunity Map Analysis
- Market Investment Opportunity Analysis (Top Investment Pockets), By Segments & By Regions
Global Chemotherapy Drugs Estimates & Historical Trend Analysis (2019 – 2022)
Global Chemotherapy Drugs Estimates & Forecast Trend Analysis, by Indication
- Global Chemotherapy Drugs Revenue (US$ Mn) Estimates and Forecasts, by Indication, 2019 to 2032
- Oncology/Cancer
- Bone Marrow Diseases
- Immune System Disorders
- Others
Global Chemotherapy Drugs Estimates & Forecast Trend Analysis, by Type
- Global Chemotherapy Drugs Revenue (US$ Mn) Estimates and Forecasts, by Type, 2019 to 2032
- Alkylating Agents
- Anti-metabolites
- Plant Alkaloids and Terpenoids
- Podophyllotoxin
- Taxanes
- Topoisomerase Inhibitor
- Anti-Tumour Antibiotics
- Hormones
- Monoclonal Antibodies
- Others
Global Chemotherapy Drugs Estimates & Forecast Trend Analysis, by Dosage Forms
- Global Chemotherapy Drugs Revenue (US$ Mn) Estimates and Forecasts, by Dosage Forms, 2019 to 2032
- Capsule
- Tablets
- Injections
- Others
Global Chemotherapy Drugs Estimates & Forecast Trend Analysis, by Route of Administration
- Global Chemotherapy Drugs Revenue (US$ Mn) Estimates and Forecasts, by Route of Administration, 2019 to 2032
- Oral
- Parenteral
- Intravenous
- Subcutaneous
- Others
Global Chemotherapy Drugs Estimates & Forecast Trend Analysis, by End User
- Global Chemotherapy Drugs Revenue (US$ Mn) Estimates and Forecasts, by End Users, 2019 to 2032
- Hospitals
- Specialty Clinics
- Homecare
- Others
Global Chemotherapy Drugs Estimates & Forecast Trend Analysis, by Distribution Channel
- Global Chemotherapy Drugs Revenue (US$ Mn) Estimates and Forecasts, by Distribution Channel, 2019 to 2032
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
Global Chemotherapy Drugs Estimates & Forecast Trend Analysis, by Region
- Global Antibody-Drug Conjugates Market Revenue (US$ Mn) Estimates and Forecasts, by Region, 2019 to 2032
  - North America
  - Europe
  - Asia Pacific
  - Middle East & Africa
  - South America

North America Chemotherapy Drugs: Estimates & Forecast Trend Analysis
- North America Antibody-Drug Conjugates Market Assessments & Key Findings
  - Chemotherapy Drugs Introduction
  - Chemotherapy Drugs Size Estimates and Forecast (US$ Million) (2019 – 2031)
    - By Indication
    - By Type
    - By Dosage Forms
    - By Route of Administration
    - By Distribution Channel
    - By End User
    - By Country
      - The U.S.
      - Canada
      - Mexico

Europe Chemotherapy Drugs: Estimates & Forecast Trend Analysis
- Europe Chemotherapy Drugs Assessments & Key Findings
  - Chemotherapy Drugs Introduction
  - Chemotherapy Drugs Size Estimates and Forecast (US$ Million) (2019 – 2031)
    - By Indication
    - By Type
    - By Dosage Forms
    - By Route of Administration
    - By Distribution Channel
    - By End User
    - By Country
      - Germany
      - K.
      - France
      - Italy
      - Spain
      - Russia
      - Rest of Europe

Asia Pacific Chemotherapy Drugs: Estimates & Forecast Trend Analysis
- Asia Pacific Market Assessments & Key Findings
  - Chemotherapy Drugs Introduction
  - Chemotherapy Drugs Size Estimates and Forecast (US$ Million) (2019 – 2031)
    - By Indication
    - By Type
    - By Dosage Forms
    - By Route of Administration
    - By Distribution Channel
    - By End User
    - By Country
      - China
      - Japan
      - India
      - Australia
      - South Korea
      - ASEAN
      - Rest of Asia Pacific

Middle East & Africa Chemotherapy Drugs: Estimates & Forecast Trend Analysis
- Middle East & Africa Market Assessments & Key Findings
  - Chemotherapy Drugs Introduction
  - Chemotherapy Drugs Size Estimates and Forecast (US$ Million) (2019 – 2031)
    - By Indication
    - By Type
    - By Dosage Forms
    - By Route of Administration
    - By Distribution Channel
    - By End User
    - By Country
      - A.E.
      - Saudi Arabia
      - Egypt
      - South Africa
      - Rest of Middle East & Africa

South America Chemotherapy Drugs: Estimates & Forecast Trend Analysis
- South America Market Assessments & Key Findings
  - Chemotherapy Drugs Introduction
  - Chemotherapy Drugs Size Estimates and Forecast (US$ Million) (2019 – 2031)
    - By Indication
    - By Type
    - By Dosage Forms
    - By Route of Administration
    - By Distribution Channel
    - By End User
    - By Country
      - Brazil
      - Argentina
      - Colombia
      - Rest of South America

Competition Landscape
- Chemotherapy Drugs Competition Index, By Leading Players
- Chemotherapy Drugs Competition White Space Analysis, By Application / End-user
- Chemotherapy Drugs Competition Heat Map Analysis, By Products / Services / Solutions
- Chemotherapy Drugs Competition Regional Intensity Map Analysis, By Geographies Served
- Chemotherapy Drugs Concentration & Company Market Shares (%) Analysis, 2022
- Chemotherapy Drugs Competition Quadrant Analysis, By Leading Players / Innovators / Emerging Players / New Entrants
Company Profiles
- Mylan N.V.
  - Company Overview & Key Stats
  - Financial Performance & KPIs
  - Product / Service / Solutions Portfolio & Applications / End-uses
  - Business Strategy & Recent Developments

* Similar details would be provided for all the players mentioned below

Merck & Co., Inc.
Allergan
AstraZeneca
AbbVie Inc.
Bayer AG
Teva Pharmaceutical Industries Ltd.
Bausch Health Companies Inc.
Fresenius Kabi AG
Amneal Pharmaceuticals LLC
LEO Pharma A/S
Johnson & Johnson Private Limited
Hoffmann-La Roche Ltd
Sanofi
Amgen Inc.
Eli Lilly & Company
Novartis AG
Others

Research Methodology
- External Sources / Databases
- Internal Proprietary Database
- Primary Research
- Secondary Research
- Assumptions
- Limitations
- Report FAQs
Research Findings & Conclusion

Request Sample

Quick Contact

+13217109863

info@markettreeresearch.com

Chemotherapy Drugas Market

Report Preview

ToC

Request Sample

Related products

Artificial Pancreas Device Systems Market

Cell Culture Market

Antineoplastic Drugs Market

Dental Anaesthetics Market